Skip to main content

More Vaccinations, Experimental Drugs as Potential Ebola Contacts Rise

The World Health Organization predicts the number of cases in Democratic Republic of Congo will rise up to 300 by July.  

Written bySukanya Charuchandra
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00

ISTOCK, DK_PHOTOSThe ongoing Ebola outbreak in Democratic Republic of Congo has claimed 25 lives as of yesterday (May 29), reports Reuters, taking the total number of cases in the country to 54. This is DRC’s ninth tussle with the hemorrhagic fever since its first appearance in 1976.

The World Health Organization (WHO) is administering ring vaccinations to people who have had suspected contact, either directly or indirectly, with an Ebola patient. This means immunizing and monitoring all the individuals who have had potential contacts with patients, 906 people so far. Of those, more than 360 contacts vaccinated before Monday, reports The New York Times. The operation began in Mbandaka, a city of more than 1 million residents, last week. The rural town of Bikoro is the second site for vaccinations, which began this Monday (May 28).

A number of experimental drugs, including antibodies and antiviral options, are also available, according to Nature. WHO is awaiting the approval of DRC’s Ministry of Health to deploy them and begin trials, reports CNN.

A 2014-2016 ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related Topics

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Improving rAAV Production for Viral Vector Manufacturing

Improving rAAV Production for Viral Vector Manufacturing

cytiva logo
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Scientist holding a clear 384-well PCR microplate in a laboratory

What Dictates PCR Success Before Amplification Begins?

Integra Logo
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems

Products

Sino Biological Logo

Sino Biological Launches European Newsletter Campaign with Exclusive Welcome Gifts

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo